High vs low CPAP strategy with aerosolized calfactant in preterm infants with respiratory distress syndrome

D C Kaluarachchi1, E Gerday2, T Bahr2

  • 1Department of Pediatrics, University of Wisconsin-Madison, Madison, WI, USA. kaluarachchi@pediatrics.wisc.edu.

Insights

High versus low continuous positive airway pressure (CPAP) strategies did not differ in preventing CPAP failure in infants receiving aerosolized calfactant. Further research is needed to confirm these findings.

Area of Science:

  • Neonatal respiratory support
  • Pulmonary surfactant therapy

Background:

  • Continuous positive airway pressure (CPAP) is a common respiratory support method for preterm infants.
  • The optimal CPAP strategy to prevent CPAP failure, defined as the need for endotracheal intubation, remains unclear.
  • Aerosolized calfactant is a potential therapeutic agent for respiratory distress syndrome.

Purpose of the Study:

  • To compare the risk of CPAP failure between high and low CPAP strategies in infants receiving aerosolized calfactant.
  • To analyze data from the AERO-02 clinical trial and AERO-03 expanded access program.

Main Methods:

  • Infants born between 29 0/7 and 36 6/7 weeks of gestation were included.
  • Infants were assigned to either a low CPAP group (4-7 cm H2O) or a high CPAP group (8-10 cm H2O).
  • CPAP failure and pneumothorax rates were compared between the groups.

Main Results:

  • There were no significant differences in CPAP failure or pneumothorax rates between the high and low CPAP groups.
  • The adjusted odds ratio for CPAP failure was 0.61 (95% CI: 0.29, 1.24), indicating no statistically significant difference.
  • Baseline characteristics did not significantly alter the observed outcomes.

Conclusions:

  • The study found no difference in CPAP failure rates when comparing high versus low CPAP strategies in infants receiving aerosolized calfactant.
  • The efficacy of a high CPAP strategy in conjunction with aerosolized surfactant treatment requires further investigation in future studies.
Abstract

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
136
Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
110
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
59.2K
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen01:16

Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen

Oxygen therapy is a pivotal aspect of medical care, particularly for patients with respiratory ailments. Two prominent oxygen-delivering systems include the Venturi mask and the transtracheal oxygen catheter.
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
560
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
184
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
256